Atea Pharmaceuticals
AVIR
AVIR
111 hedge funds and large institutions have $203M invested in Atea Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 43 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 114 → 111 (-3)
30% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 43
Holders
111
Holding in Top 10
1
Calls
$10K
Puts
–
Top Buyers
| 1 | +$12.3M | |
| 2 | +$2.32M | |
| 3 | +$1.06M | |
| 4 |
Two Sigma Investments
New York
|
+$871K |
| 5 |
Two Sigma Advisers
New York
|
+$837K |
Top Sellers
| 1 | -$1.53M | |
| 2 | -$1.43M | |
| 3 | -$1.13M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$953K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$565K |
